Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

BLISS GVS PHARMA LTD. - 506197 - Intimation About Approval Letters Received From BSE Limited And National Stock Exchange Of India Limited For Re-Classification/Removal Of Shareholding From "Promoter And Promoter Group Category' To "Public Category' As Per Regulation 31A Of SEBI LODR

 This is with reference to the Application Submitted to BSE and NSE for seeking Re-classification/Removal of Shareholding of following persons from Promoter and Promoter Group Category to Public Category as per Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to the Stock Exchanges on October 23, 2020. 1. Gautam Rasiklal Ashra 2. Arjun Gautam Ashra 3. Antara Gautam Ashra 4. Mamta Gautam Ashra 5. Gautam Rasiklal Ashra on behalf of Arjun & Antara Trust 6. Vijayaben Kanji Ashra 7. Kanji Forex Private Limited 8. Kanji Pitamber Forex Private Limited 9. Genteel Trading Company Private Limited 10. Mangesh Ghanashyam Wagle 11. Mangesh Ghanashyam Wagle HUF We are pleased to inform you that, we have received the approval letter No. LIST/COMP/PC/009/2020-21 dated December 14, 2020 from BSE and NSE/LIST/108 dated December 14, 2020 from NSE approving above re-classification/removal of shareholding from Promoter and Promoter Group Category to Public Category
15-12-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 13, 2020 for Arjun Gautam Ashra
13-11-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 13, 2020 for Gautam Rasiklal Ashra
13-11-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 12, 2020 for Gautam Rasiklal Ashra & Arjun Gautam Ashra
12-11-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 11, 2020 for Arjun Gautam Ashra
12-11-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 11, 2020 for Gautam Rasiklal Ashra
12-11-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed disclosure of Related Party Transactions on the basis on consolidated financial statements for the half year ended September 30, 2020. Kindly take the above information on record.
05-11-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2020

 Please find enclosed herewith the half yearly compliance certificate issued by Company Secretary in Practice as per Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2020. Kindly take the same on record.
29-10-2020
Bigul

Bliss GVS Pharma Ltd - 506197 - Intimation Of Submission Of Application For Re-Classification Of Promoters Under Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 To The Stock Exchanges

 In accordance with provisions of clause (c) of sub-regulation (8) of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') we wish to inform you that, the Company today i.e. 23rd October, 2020 had submitted an application for Re-classification of shareholding of following persons from 'Promoter & Promoter Group Category' to 'Public Category' and/or Removal of their Names from 'Promoter & Promoter Group Category' of the Company under Regulation 31A of the Listing Regulations to BSE Limited and National Stock Exchange of India Ltd. 1) Gautam Rasiklal Ashra 2) Arjun Gautam Ashra 3) Antara Gautam Ashra 4) Mamta Gautam Ashra 5) Gautam Rasiklal Ashra on behalf of Arjun & Antara Trust 6) Vijayaben Kanji Ashra 7) Kanji Forex Private Limited 8) Kanji Pitamber Forex Private Limited 9) Genteel Trading Company Private Limited 10) Mangesh Ghanashyam Wagle 11) Mangesh Ghanashyam Wagle HUF
23-10-2020
Bigul

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the quarter and half year ended September 30, 2020 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on October 23, 2020.
23-10-2020
Next Page
Close

Let's Open Free Demat Account